U.S. pharmaceutical industry

Statistics report about the U.S. pharmaceutical industry

U.S. pharmaceutical industry

This report presents graphs and tables about the U.S. pharmaceutical industry. The U.S. pharma industry has a huge influence on the global pharmaceutical market. This report includes some of the most important key figures on U.S. revenues, top companies and products, medicine use facts, research and development, the U.S. public's view on the industry, and an outlook for the coming years.

Table of contents

Contribution to global pharma

5
  • Premium Statistic World pharmaceutical market distribution by submarket 2014-2023
  • Premium Statistic World pharmaceutical sales 2020-2023 by region
  • Basic Statistic Market share of the leading global pharmaceutical markets 2022
  • Premium Statistic Top global pharmaceutical markets: growth rate 2022
  • Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022

Overview

6
  • Premium Statistic U.S. total medicine spending 2002-2022
  • Basic Statistic Leading therapy areas for U.S. drug spending 2020
  • Premium Statistic U.S. top prescribed drugs based on sales 2022
  • Premium Statistic Top pharma products by prescriptions U.S. 2021
  • Premium Statistic Pharmaceutical channel distribution by U.S. spending 2017-2019
  • Premium Statistic U.S. biopharmaceutical export volume 2002-2022

Companies

6
  • Premium Statistic 2024 list of top U.S. biotech and pharmaceutical companies based on revenue
  • Premium Statistic Pharmaceutical corporations by U.S. revenue 2022
  • Basic Statistic AbbVie's revenue 2010-2023
  • Premium Statistic Pfizer's total revenue 2006-2023
  • Premium Statistic Bristol-Myers Squibb's revenue 2006-2023
  • Premium Statistic Johnson & Johnson's total sales 2005-2023

Research and development

7
  • Basic Statistic Research and development expenditure: U.S. pharmaceutical industry 1995-2022
  • Premium Statistic U.S. pharma industry R&D spending as a percent of total revenues 1990-2022
  • Basic Statistic Pharmaceuticals: cost of drug development in the U.S. since 1975
  • Premium Statistic Number of novel drugs approved annually by CDER 2008-2023
  • Premium Statistic Number of orphan designations accepted in the U.S. 2003-2023
  • Basic Statistic U.S. sales of new brand medicines 2012-2021
  • Basic Statistic R&D expenditure per employee in U.S. sectors 2003-2017

Generics

5
  • Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
  • Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
  • Premium Statistic Branded vs. generic U.S. drug prescriptions dispensed 2005-2021
  • Premium Statistic Savings through generic drug usage in the U.S. 2008-2022
  • Premium Statistic Sales share at risk of pharmaceuticals due to patent expiries U.S. 2022

Public view on pharma

6
  • Premium Statistic Share of U.S. people who had a favorable view of pharmaceutical companies 2021
  • Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
  • Premium Statistic Share of U.S. adults who approve pharmaceutical companies' drug price handling 2021
  • Basic Statistic Share of people who had a favorable view of Pfizer in U.S. 2021
  • Basic Statistic Share of people who had a favorable view of Moderna in U.S. 2021
  • Premium Statistic Share of people who had a favorable view of J&J in U.S. 2021

Outlook

4
  • Premium Statistic World pharmaceutical sales by region forecast 2027
  • Premium Statistic Sales at risk of pharmaceuticals due to patent expiries U.S. 2022
  • Basic Statistic Leading U.S. pharmaceutical products by revenue 2026
  • Basic Statistic U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)